Skip to main content

EXPONENT INC

For the period ended Jul 4, 2025. Filed Aug 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jul 4, 2025 · Filed Aug 8, 2025

EXPO$85.46+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

Rule 10b5-1 Plans

The following table summarizes the adoption by the Company’s directors and officers of trading plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the three months ended July 4, 2025:

Name and TitleAdoption DateExpiration DateAggregate Number of Securities to be Sold (1)Aggregate Number of Securities to be Purchased
Catherine Ford Corrigan, President and Chief Executive OfficerMay 15, 2025August 30, 202616,1280

-30 -

(1)

Does not include an additional indeterminable number of shares permitted to be sold pursuant to the Rule 10b5-1 (c) trading arrangement in order to satisfy tax obligations related to stock option exercises.

During the three months ended July 4, 2025, no pre-existing trading plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) were modified or terminated by the Company’s directors and officers, andno other written trading arrangements that are not intended to qualify for the Rule 10b5-1(c) affirmative defense were adopted, modified, or terminated by the Company’s directors and officers.

-31 -

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.